Collegium to Present at Upcoming Investor Conferences
The Jefferies Global Healthcare Conferenceon Thursday, June 7th at 9:30 a.m. ETin New York City The William Blair Growth Stock Conferenceon Wednesday, June 13th at 7:00 a.m. ETin Chicago
Collegium is a specialty pharmaceutical company focused on becoming the leader in responsible pain management by developing and commercializing innovative, differentiated products for patients suffering from pain.
About Xtampza ER
Xtampza® ER is Collegium’s first product utilizing the DETERx technology platform. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone approved by the
Source: Collegium Pharmaceutical, Inc.